List of works - Gonzalo Carreño-Tarragona

Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III

scientific article published on 22 April 2015

Coronary response to diadenosine triphosphate after ischemia-reperfusion in the isolated rat heart.

scientific article published on 13 August 2012

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?

scientific article published on 10 October 2020

Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.

scientific article published on 29 March 2017

Effects of age and caloric restriction on the cardiac and coronary response to endothelin-1 in rats

scientific article published on 01 November 2014

Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors

scientific article

Effects of early overnutrition on the renal response to Ang II and expression of RAAS components in rat renal tissue

scientific article published on 8 July 2017

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes

scientific article published on 22 June 2018

Fatal graft-versus-host disease after allogeneic stem cell transplantation in a patient recently exposed to nivolumab.

scientific article published in January 2017

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

scientific article published on 07 January 2021

Lupus anticoagulant-hypoprothrombinemia syndrome: A rare association in systemic lupus erythematosus

scientific article published on 04 August 2015

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

scientific article published on 04 August 2020

Papain-treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti-CD38-based therapies